Pure Global

Effect of Phenolic Acids on the Human Vasculature - Trial NCT03599128

Access comprehensive clinical trial information for NCT03599128 through Pure Global AI's free database. This phase not specified trial is sponsored by Société des Produits Nestlé (SPN) and is currently Completed. The study focuses on Endothelial Dysfunction. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT03599128
Completed
other
Trial Details
ClinicalTrials.govNCT03599128
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Effect of Phenolic Acids on the Human Vasculature

Study Focus

Endothelial Dysfunction

43.3 mg hydrolyzed green coffee extract

Interventional

other

Sponsor & Location

Société des Produits Nestlé (SPN)

Crawley, Australia

Timeline & Enrollment

N/A

Mar 13, 2018

Dec 11, 2018

20 participants

Primary Outcome

Efficacy by oral administration of phenolic acid in improving endothelial function

Summary

This study evaluates effects of different doses of phenolic acids on healthy volunteers.

ICD-10 Classifications

Other peripheral vascular diseases
Atherosclerosis of arteries of extremities
Other specified peripheral vascular diseases
Renovascular hypertension
Other disorders of arteries and arterioles

Data Source

ClinicalTrials.gov

NCT03599128

Non-Device Trial